While these
have been on, COVID-19 vaccines have been unequally distributed around the world. Rich countries signed agreements to buy up the bulk when vaccines were still being developed. Many players are involved in the development and distribution of COVID-19 vaccines countries and their governments; research institutions such as Oxford University; and pharmaceutical companies such as AstraZeneca, Johnson & Johnson, GlaxoSmithKline, Pfizer, Moderna, Novavax and the Serum Institute of India. Global alliances have also been participating in the process, such as GAVI, which is a global alliance facilitating vaccine production and distribution, the Coalition for Epidemic Preparedness Innovations or CEPI, and COVAX, an alliance specifically to coordinate distribution of COVID-19 vaccines that is led by GAVI ad CEPI. The Gates Foundation helped set up both GAVI and CEPI, and had contributed to funding COVAX.
India appreciates Biden admin s decision to back TRIPS waiver for Covid vaccines
Premium
(Bloomberg)
Lalit K Jha
, PTI
In the past few months, the Indian Embassy had made a focused outreach on the need for equitable access to Covid-19 vaccines in the developing world
Share Via
Read Full Story
India has appreciated the Biden administration s decision to support a proposal moved by it and South Africa to temporarily waive some Trade-Related Aspects of Intellectual Property Rights (TRIPS) rules amid the coronavirus pandemic.
For the past several weeks, India s Ambassador to the US Taranjit Singh Sandhu, along with the diplomats from South Africa, had been meeting US lawmakers and officials regarding the proposal.
A patently wrong regime
Updated:
Updated:
April 28, 2021 01:14 IST
Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare
Share Article
AAA
Over the last few decades, intellectual property rules have served as a lethal barrier to the right to access healthcare
Even an unprecedented pandemic can do little, it appears, to upset the existing global regime governing monopoly rights over the production and distribution of life-saving drugs. If anything, since the onset of COVID-19, we’ve only seen a reaffirmation of intellectual property rules that have served as a lethal barrier to the right to access healthcare over the last few decades. The neo-liberal order, under which these laws exist, is so intractable today that a matter as seemingly simple as a request for a waiver on patent protections is seen as a claim unworthy of exception.
Katherine Tai. File
| Photo Credit:
AFP
The move by India, South Africa and several other countries has been supported by more than 60 top American lawmakers, most of whom are progressives. The U.S. remained non-committal on the move by India and South Africa to get Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 vaccine before the WTO so that the doses are accessible and affordable to low- and middle-income countries.
The move by India, South Africa and several other countries has been supported by more than 60 top American lawmakers, most of whom are progressives.
U.S. Trade Representatives Katherine Tai, in her address to the World Trade Organisation (WTO) virtual conference on COVID-19 vaccine equity on Wednesday, however, did not weigh in on the request made by India and South Africa.
Why commercial interest of only Big Pharma sacrosanct, India asks developed countries
Premium
2 min read
Share Via
Read Full Story
New Delhi: India has pressed its demand for a waiver of intellectual property rights on covid-19 vaccines before the World Trade Organization (WTO), asking why the commercial interests of Big Pharma alone are being protected even as industries reel under the impact of the pandemic and countries struggle to access vaccines.
“Globally, governments have intervened to suspend air transport and restrict mobility in order to prevent the spread of coronavirus. Sectors like civil aviation, travel and tourism, hospitality, small businesses including MSMEs continue to be severely impacted by such state interventions. These sectors are also important for the global economy, for growth, for employment. Certainly, governments are not against the interest of these sectors. We would like to know that why commercial interests of only few companies are so sacrosan